Management options for stage 1 nonseminomatous germ cell tumors of the testis
Management of clinical stage I non seminomatous germ cell tumor includes surveillance, primary chemotherapy and retroperitoneal lymph node dissection. Stratifying clinical stage I disease to high- and low-risk groups for harboring micrometastic retroperitoneal disease (pathologic stage B) is based o...
Main Author: | Stephen D.W Beck |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | Indian Journal of Urology |
Subjects: | |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2010;volume=26;issue=1;spage=72;epage=75;aulast=Beck |
Similar Items
-
Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
by: Alexander P.M. Jay, et al.
Published: (2021-07-01) -
Long-term clinical outcome in patients with stage-i nonseminomatous germ cell cancer: a critical review of own treatment modalities in a retrospective study
by: Sandra Seseke, et al.
Published: (2008-12-01) -
Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: initial operative experience
by: Kai Yao, et al.
Published: (2014-02-01) -
Outcomes following retroperitoneal lymph node dissection in postchemotherapy residual masses in advanced testicular germ cell tumors
by: Prabhjot Singh, et al.
Published: (2016-01-01) -
Predictors of viable germ cell tumor in postchemotherapeutic residual retroperitoneal masses
by: Khalid Al Othman, et al.
Published: (2014-01-01)